Vertex Pharmaceuticals
VRTX
S$603.10
Share price
1.64%
Change (1 day)
-9.78%
Change (1 year)
Categories
Vertex Pharmaceuticals (VRTX) - Net assets
Net assets on the balance sheet as of March 2025 : S$21.23 Billion
According to Vertex Pharmaceuticals's latest financial reports the company has S$21.23 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Vertex Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $S$22.30 B | -3.93% |
| 2023-12-31 | $S$23.21 B | 24.49% |
| 2022-12-31 | $S$18.65 B | 36.6% |
| 2021-12-31 | $S$13.65 B | 18.81% |
| 2020-12-31 | $S$11.49 B | 40.08% |
| 2019-12-31 | $S$8.20 B | 35.4% |
| 2018-12-31 | $S$6.05 B | 121.82% |
| 2017-12-31 | $S$2.73 B | 41.04% |
| 2016-12-31 | $S$1.93 B | 25.2% |
| 2015-12-31 | $S$1.54 B | 6.8% |
| 2014-12-31 | $S$1.44 B | -15.72% |
| 2013-12-31 | $S$1.71 B | 17.51% |
| 2012-12-31 | $S$1.46 B | 21.62% |
| 2011-12-31 | $S$1.20 B | 85.22% |
| 2010-12-31 | $S$0.64 B | -57.82% |
| 2009-12-31 | $S$1.53 B | 350.56% |
| 2008-12-31 | $S$0.34 B | -12.5% |
| 2007-12-31 | $S$0.39 B | -49.68% |
| 2006-12-31 | $S$0.77 B | 94.81% |
| 2005-12-31 | $S$0.39 B | 588.76% |
| 2004-12-31 | $S$57.81 M | -82.35% |
| 2003-12-31 | $S$0.32 B | -50.12% |
| 2002-12-31 | $S$0.65 B | -25.35% |
| 2001-12-31 | $S$0.87 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | S$24.56 B | 15.65% | 🇺🇸 USA |
 AbbVie ABBV | S$1.88 B | -91.14% | 🇺🇸 USA |
 Merck MRK | S$62.31 B | 193.40% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | S$22.46 B | 5.77% | 🇺🇸 USA |
 Johnson & Johnson JNJ | S$100.56 B | 373.49% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | S$0.12 B | -99.43% | 🇺🇸 USA |